FDA plans ultra-fast review of three psychedelic drugs following Trump directive
The Food and Drug Administration says it will offer ultra-fast review to three psychedelic drugs being studied for hard-to-treat mental health conditions, including major depression
April 24, 2026
Louisiana DCFS concerns: Report reveals new fatality data, foster care children held in hospitals
Elon Musk tells his side of OpenAI's beginnings in trial pitting him against CEO Sam Altman
Three license plate reader cameras stolen near Highway 49
Afghan man convicted of conspiracy in deadly suicide bombing at Kabul airport during US withdrawal
Police arrest 2 teens as alleged gunmen in homicide
Elon Musk gets an apology from California regulators as a SpaceX lawsuit is settled
Broncos' 2-time Pro Bowl safety Justin Simmons retires after 32 interceptions in his 9-year career
The first Kentucky Derby since the death of trainer D. Wayne Lukas has a different vibe
New court filing details timeline and suspect’s extensive arsenal in White House Correspondents’ Dinner shooting